<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01398722</url>
  </required_header>
  <id_info>
    <org_study_id>Guch-012</org_study_id>
    <nct_id>NCT01398722</nct_id>
  </id_info>
  <brief_title>Effect of Intensive Insulin Therapy on Clinical Prognosis of Infants Undergoing Cardiac Surgery</brief_title>
  <official_title>Study of the Relationship Between Intensive Insulin Therapy and Clinical Prognosis in Infants Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators sought to determine whether intensive insulin therapy can improve prognosis
      of infants undergoing cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies showed that tight blood glucose control with insulin during intensive care
      reduced morbidity and mortality of surgical and medical intensive care patients. Blood sugar
      control with intravenous insulin may improve prognosis of patients undergoing cardiac
      surgery. It is not clear what the best insulin regimen is or what is the best blood sugar
      target in these patients. So far, most of researches have focused on adult patients but
      little on infants. The current prospective, randomized, controlled study will assess the
      impact of intensive insulin therapy on the outcome of infants undergoing cardiac surgery. On
      admission, patients will be randomly assigned to either strict normalization of blood glucose
      ( 110-150 mg/dl) with intensive insulin therapy or the conventional approach, in which blood
      glucose levels are maintained between 150 and 180 mg/dl.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical markers of myocardial injury(troponin and creatine kinase MB)</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute renal failure</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory failure</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay, and ICU readmissions</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke and reversible ischemic neurologic deficit</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Index</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inotropic Scores</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative complications</measure>
    <time_frame>average 1 month during the hospitalization</time_frame>
    <description>Perioperative complications including sternal wound infection (deep and superficial), bacteremia, pneumonia, and major cardiovascular events (acute myocardial infarction, congestive heart failure, and cardiac arrhythmias</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Intensive insulin therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive insulin therapy(Blood glucose target: 110-150 mg/dL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional insulin therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional insulin therapy(Blood glucose target: 150-180 mg/dl)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intensive insulin therapy</intervention_name>
    <description>Titration of the IV insulin rate for glucose goal 110-150 mg/dL</description>
    <arm_group_label>Intensive insulin therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional insulin therapy</intervention_name>
    <description>Titration of the IV insulin rate for glucose goal 150-180 mg/dl</description>
    <arm_group_label>Conventional insulin therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants underwent cardiac surgery with cardiopulmonary bypass

        Exclusion Criteria:

          -  Therapy restricted upon admission

          -  Preoperative liver or kidney disease or dysfunction

          -  Preoperative coagulation disorder

          -  Palliative operation or a second operation

          -  Type 1 diabetes

          -  Type 2 diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dinhhua Yi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chunhu Gu, MD</last_name>
    <email>guchunhu@fmmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chunhu Gu, MD</last_name>
      <email>guchunhu@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Chunhu Gu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yukun Cao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2011</study_first_submitted>
  <study_first_submitted_qc>July 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2011</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Chunhu Gu</name_title>
    <organization>Xijing Hospital</organization>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>prognosis</keyword>
  <keyword>intensive insulin therapy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

